Fund Family UTI Mutual Fund
Fund Class Sector - Pharma & Healthcare
Not Ranked
This scheme is not ranked by CRISIL.
View Top ranked funds in other categories
| Period | Returns (%) | Rank # |
|---|---|---|
| 1 mth | -3.0 | 3 |
| 3 mth | 2.5 | 3 |
| 6 mth | 3.1 | 3 |
| 1 year | -0.5 | 3 |
| 2 year | 6.9 | 2 |
| 3 year | 24.3 | 2 |
| 5 year | 12.0 | 2 |
# Moneycontrol Rank within 3 Sector - Pharma & Healthcare Schemes.
| Year | Qtr 1 | Qtr 2 | Qtr 3 | Qtr 4 | Annual |
|---|---|---|---|---|---|
| 2012 | 6.9 | - | - | - | - |
| 2011 | -7.8 | 6.1 | -7.2 | -0.7 | -10.0 |
| 2010 | 11.7 | 8.9 | 1.4 | 4.1 | 30.1 |
| 2009 | -1.3 | 18.2 | 25.0 | -0.2 | 65.6 |
| 2008 | -15.6 | 9.7 | -7.5 | -18.5 | -31.7 |
| 2007 | -4.4 | 13.3 | -6.5 | 10.6 | 10.6 |
* Returns over 1 year are Annualised
Fund returns v/s Category average (Sector - Pharma & Healthcare)
| 1 mth (%) | 3 mth (%) | 6 mth (%) | 1 yr (%) | 2 yr (%) | 3 yr (%) | 5yr (%) | |
| Fund Returns | -3.0 | 2.5 | 3.1 | -0.5 | 6.9 | 24.3 | 12.0 |
| Category avg | -2.3 | 5.8 | 7.2 | 5.1 | 9.8 | 27.1 | 12.9 |
| Difference of Fund returns and Category returns | -0.7 | -3.3 | -4.1 | -5.6 | -2.9 | -2.8 | -0.9 |
| Best of category | -2.0 | 5.9 | 9.3 | 7.7 | 10.8 | 31.0 | 19.6 |
| Worst of category | -3.0 | 2.5 | 3.1 | -0.5 | 6.3 | 24.2 | 6.3 |
| Benchmark returns # | -1.6 | 5.2 | 8.6 | 6.9 | 12.0 | -- | -- |
| Difference of Fund returns and Benchmark returns | -1.4 | -2.7 | -5.5 | -7.4 | -5.1 | 24.3 | 12.0 |
Investment Objective
Investment will be made in stocks of companies engaged in manufacturing of Pharmaceuticals bulk drugs, formulations & OTC drugs, medical equipment and accessories, personal healthcare products and also companies owning/managing hospitals etc.
| Fund Type | Open-Ended |
|---|---|
| Investment Plan | Dividend |
| Launch date | Jun 26, 1999 |
| Benchmark | CNX Pharma |
| Asset Size (Rs cr) | 93.37 (Mar-31-2012) |
| Minimum Investment | Rs.5000 |
| Last Dividend | Rs.1.70 (Oct-28-2010) View Dividend History |
| Bonus | N.A. |
| Fund Manager | Lalit Nambiar View performance of schemes managed by the Fund Manager |
| Notes | UTI Pharma & Healthcare Fund - Income Option Newly introduced w.e.f August 01, 2005. |
| Entry Load | N.A |
|---|---|
| Exit Load | 1.00% |
| Load Comments | Exit Load 1% if redeemed within 1 Year from the date of allotment. |
| Regd. Office | UTI Tower, Gn Block, Bandra-Kurla Complex, Bandra (E), Mumbai, 400051 |
|---|---|
| Tel. No. | 66786666 |
| Fax No. | 26524921 |
| uti@giasbm01.vsnl.net.in | |
| Website | http://www.utimf.com |
| Sector - Pharma & Healthcare | Crisil Rank | Assets (Rs.cr) |
|||||
| 3mth (%) | 6mth (%) | 1yr (%) | 3yr (%) | 5yr (%) | |||
| Reliance Pharma Fund (G) | Not Ranked |
563.56 | 3.6 | 7.4 | 0.5 | 31.0 | 19.6 |
| SBI Magnum Pharma Fund (G) | Not Ranked |
41.05 | 5.9 | 9.3 | 7.7 | 24.2 | 6.3 |
| UTI Pharma & Health (G) | Not Ranked |
93.37 | 2.5 | 3.1 | -0.5 | 24.3 | 12.0 |
| * Returns over 1 year are Annualised | More » | ||||||
| Equity | Sector | Value (Rs cr) |
Asset % |
|---|---|---|---|
| Sun Pharma | Pharmaceuticals | - | 17.36 |
| Dr Reddys Labs | Pharmaceuticals | - | 17.34 |
| Lupin | Pharmaceuticals | - | 9.99 |
| Cipla | Pharmaceuticals | - | 9.73 |
| GlaxoSmithKline | Pharmaceuticals | - | 6.99 |
| Wyeth | Pharmaceuticals | - | 5.61 |
| Pfizer | Pharmaceuticals | - | 4.80 |
| Cadila Health | Pharmaceuticals | - | 4.73 |
| Divis Labs | Pharmaceuticals | - | 3.97 |
| Biocon | Pharmaceuticals | - | 3.23 |
| Sector | % | 1-Year HighLow |
|
|---|---|---|---|
| Pharmaceuticals | 94.72 | 95.75 | 90.53 |
| Equity | 94.72 |
| Others | 0.00 |
| Debt | 1.33 |
| Mutual Funds | N.A |
| Money Market | 0.00 |
| Cash / Call | 3.94 |
| Holdings | (%) |
|---|---|
| Top 5 | 61.41 |
| Top 10 | 83.75 |
| Sector | (%) |
|---|---|
| Top 3 | 94.72 |
UTI MF wants to sack CMO to revive dipping fortunes
May 08, 2012 at 17:26 | Source:
Oct 25, 2011
Oct 25, 2011
Oct 25, 2011
Quick Links